EMCAX
Price
$69.11
Change
+$0.39 (+0.57%)
Updated
Dec 3 closing price
Net Assets
24.81M
VSGIX
Price
$85.51
Change
+$0.83 (+0.98%)
Updated
Dec 3 closing price
Net Assets
39.74B
Interact to see
Advertisement

EMCAX vs VSGIX

Header iconEMCAX vs VSGIX Comparison
Open Charts EMCAX vs VSGIXBanner chart's image
Empiric
Price$69.11
Change+$0.39 (+0.57%)
VolumeN/A
Net Assets24.81M
Vanguard Small Cap Growth Index I
Price$85.51
Change+$0.83 (+0.98%)
VolumeN/A
Net Assets39.74B
EMCAX vs VSGIX Comparison Chart in %
View a ticker or compare two or three
VS
EMCAX vs. VSGIX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMCAX is a StrongBuy and VSGIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGIX has more cash in the bank: 39.7B vs. EMCAX (24.8M). VSGIX pays higher dividends than EMCAX: VSGIX (0.55) vs EMCAX (0.00). EMCAX was incepted earlier than VSGIX: EMCAX (30 years) vs VSGIX (26 years). EMCAX (2.18) is less costly to investors than VSGIX (0.06). VSGIX is a more actively managed with annual turnover of: 21.00 vs. EMCAX (5.00). EMCAX has a lower initial minimum investment than VSGIX: EMCAX (2500) vs VSGIX (5000000). VSGIX annual gain was more profitable for investors over the last year : 0.15 vs. EMCAX (-0.97). EMCAX return over 5 years is better than : 28.50 vs. VSGIX (21.88).
EMCAXVSGIXEMCAX / VSGIX
Total Expense Ratio2.180.063,633%
Annual Report Gross Expense Ratio2.180.063,633%
Fund Existence30 years26 years-
Gain YTD5.3477.55271%
Front Load6%N/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets24.8M39.7B0%
Annual Yield % from dividends0.000.55-
Returns for 1 year-0.970.15-635%
Returns for 3 years30.4739.9976%
Returns for 5 years28.5021.88130%
Returns for 10 years124.47146.2285%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRS2.700.09
+3.64%
Aclaris Therapeutics
NABL7.300.14
+2.03%
N-able
OBDC13.22-0.03
-0.19%
Blue Owl Capital Corp
PM154.62-1.53
-0.98%
Philip Morris International
XLO0.71-0.03
-4.00%
Xilio Therapeutics